LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today that Arunesh Verma has joined the company as president of Fresenius Kabi USA and a member of the company’s global Executive Leadership Team, reporting to Pierluigi Antonelli, CEO of Fresenius Kabi.

伊利诺伊州苏黎世湖。-（商业新闻短讯）--费森尤斯·卡比（Fresenius Kabi）今天宣布，阿鲁内斯·维尔玛（Arunesh Verma）已加入该公司，担任费森尤斯·卡比（Fresenius Kabi USA）总裁和该公司全球执行领导团队成员，并向费森尤斯·卡比（Fresenius Kabi）首席执行官皮埃尔路易吉·安东内利（Pierluigi Antonelli。

Verma is responsible for the commercial operations of Fresenius Kabi in the United States. He succeeds John Ducker, who is retiring after a highly successful 35-year career with Fresenius Kabi.

Verma负责费森尤斯·卡比在美国的商业运营。他接替了约翰·杜克（JohnDucker），后者在费森尤斯·卡比（FreseniusKabi）35年的职业生涯中取得了巨大成功，即将退休。

“I am very pleased to welcome Arunesh Verma to our company at a time when we are successfully executing our #Vision2026 transformation in line with #FutureFresenius, strengthening our commercial operations, and bringing online advanced new U.S. manufacturing capabilities – all designed to support U.S.

“我很高兴欢迎Arunesh Verma加入我们的公司，因为我们正在成功地执行我们的#Vision2026转型，以符合#FutureFresenius，加强我们的商业运营，并将先进的美国新制造能力上线，所有这些都是为了支持美国。

caregivers,” said Pierluigi Antonelli. “At the same time, I want to thank John Ducker for his outstanding leadership and achievement over 35 years. His contributions have shaped our company’s growth and reputation in the U.S. in profound ways.”.

照顾者，”皮尔路易吉·安东内利说。“同时，我要感谢约翰·杜克（JohnDucker）35年来的杰出领导和成就。他的贡献深刻地塑造了我们公司在美国的发展和声誉。”。

Fresenius Kabi, an operating company of Fresenius, is a global health care leader that specializes in medicines and technologies for infusion, transfusion and clinical nutrition. In the U.S., Fresenius Kabi plays an essential role in patient care as a leading developer and manufacturer of injectable medicines and biosimilars used in hospitals and other sites of care.

费森尤斯·卡比（Fresenius Kabi）是费森尤斯（Fresenius）的一家运营公司，是一家全球医疗保健领导者，专门从事输液、输血和临床营养的药物和技术。在美国，费森尤斯·卡比（Fresenius Kabi）作为医院和其他护理场所使用的注射药物和生物仿制药的领先开发商和制造商，在患者护理中发挥着至关重要的作用。

The company is also a leader in clinical nutrition and medical technologies that infuse medicines into patients, that collect and process human blood, and that enable cell and gene therapies..

该公司也是临床营养和医疗技术的领导者，这些技术可以为患者注入药物，收集和处理人体血液，并实现细胞和基因治疗。。

“I am thrilled to join Fresenius Kabi, a highly respected global leader with an outstanding reputation in the U.S. and deep roots in health care worldwide,” Verma said. “Fresenius Kabi specializes in putting essential medicines and technologies in the hands of people who care for patients – and this is a purpose to which I have devoted my career of more than 22 years.”.

Verma说：“我很高兴加入费森尤斯·卡比（FreseniusKabi），他是一位备受尊敬的全球领导者，在美国享有卓越声誉，在全球医疗保健领域拥有深厚的根基。”。“费森尤斯·卡比（Fresenius Kabi）专注于将基本药物和技术交给照顾患者的人手中，这是我22年多职业生涯中一直致力于的目标。”。

Verma joins Fresenius Kabi from Cipla, a global pharmaceutical company, where he was CEO of Cipla North America and a member of the company’s global Management Council. He started his career as a medical sales representative with Novartis and has held roles of increasing responsibility at Cipla, Torrent Pharma, Sandoz and Dr.

Verma加入了来自全球制药公司Cipla的Fresenius Kabi，他曾任Cipla北美首席执行官，也是该公司全球管理委员会成员。他在诺华开始了他的医疗销售代表生涯，并在Cipla、Torrent Pharma、Sandoz和Dr。

Reddy’s Laboratories, where he has led pharmaceutical businesses and functions in the U.S., Central America, Australia and Asia. Verma holds a master’s degree in business management, marketing and communications from Symbiosis Institute of Business Management and a bachelor’s degree in pharmaceutical sciences, pharmacology and pharmaceutics from the University of Mumbai..

雷迪实验室（Reddy's Laboratories），他曾在美国、中美洲、澳大利亚和亚洲领导制药业务和职能。Verma拥有Symbiosis Institute of business management的商业管理、营销和传播硕士学位，以及孟买大学的药学、药理学和药剂学学士学位。。

About Fresenius Kabi

关于费森尤斯·卡比

Fresenius Kabi (www.fresenius-kabi.com/us) is a global health care company that specializes in injectable medicines, biosimilars, and technologies for infusion, transfusion, and clinical nutrition. The company’s products and services are used to help care for patients with critical and chronic conditions.

Fresenius Kabi（www.Fresenius-Kabi.com/us）是一家全球医疗保健公司，专门从事注射药物、生物仿制药以及输液、输血和临床营养技术。该公司的产品和服务用于帮助护理危重和慢性病患者。

The company’s U.S. headquarters is in Lake Zurich, Illinois. The company’s global headquarters is in Bad Homburg, Germany. To learn about U.S. career opportunities at Fresenius Kabi USA, visit us at www.fresenius-kabi.com/us/join-us and follow us on LinkedIn..

该公司的美国总部位于伊利诺伊州的苏黎世湖。该公司的全球总部位于德国巴德洪堡。要了解美国在Fresenius Kabi USA的职业机会，请访问我们的网站www.Fresenius-Kabi.com/us/join-us，并在LinkedIn上关注我们。。